Empagliflozin as First Line in Patients with Type 2 and Fatty Liver Disease
Dapagliflozin Use in Managing Type 1 Diabetes
Sotagliflozin Shows Promise As Adjunct To Insulin Therapy
Sotagliflozin As Adjunct Therapy for People with Type 1 to Increase Time in Target Range